查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1957881

2026年全球經皮給藥系統市場報告

Transdermal Drug Delivery Systems Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，經皮給藥系統的市場規模經歷了顯著成長。預計該市場規模將從2025年的400.1億美元成長到2026年的430.9億美元，複合年成長率（CAGR）為7.7%。過去幾年成長要素包括口服藥物的局限性、慢性病的普遍流行、提高患者用藥依從性的需求、貼劑技術的進步以及醫院對給藥系統的日益普及。

預計未來幾年，經皮給藥系統的市場規模將強勁成長，2030年將達到579.4億美元，複合年成長率（CAGR）為7.7%。預測期內的成長要素包括：自我給藥療法的普及、穿戴式醫療設備的廣泛應用、慢性疾病負擔的加重、藥物遞送技術的創新以及門診服務的擴展。預測期內的關鍵趨勢包括：含藥貼片系統的日益普及、疼痛管理應用的擴展、對控釋藥物的需求、居家給藥的成長以及微針技術的創新。

未來幾年，慢性病盛行率的不斷上升預計將推動經皮給藥系統市場的成長。慢性病是指需要持續管理的長期健康狀況，例如糖尿病和心臟病，這些疾病會限制日常生活。這些疾病的增加部分歸因於久坐的生活方式，這種生活方式導致體力活動減少，進而造成體重增加、心血管風險上升和代謝失衡。經皮給藥系統透過持續、可控制地經皮釋放藥物，在慢性病管理中發揮至關重要的作用，它能夠提高患者的用藥依從性，並維持穩定的治療水平。例如，根據美國公共衛生研究機構健康指標與評估研究所 (IHME) 於 2023 年 6 月發布的報告，全球有超過 5 億人患有糖尿病，預計到 2050 年，這一數字將加倍以上，達到 13 億人。因此，慢性病盛行率的上升趨勢正在推動經皮給藥系統市場的擴張。

經皮給藥系統市場的主要企業正致力於微針技術等技術創新，以提高藥物吸收率並增強患者依從性。微針技術是一種微創設備，可透過皮膚無痛給藥，取代傳統的注射方式。例如，韓國大宇製藥有限公司於2024年10月發布了其微針平台「CLOPAM」。此技術可提高藥物輸送效率，減少注射帶來的不適感，並達到可控制、持續的藥物釋放。其主要目標是提供一種無痛且穩定的給藥方式，取代口服和注射藥物，從而提高患者依從性和治療效果。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球經皮給藥系統市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 永續性、氣候技術、循環經濟
    • 人工智慧（AI）和自主人工智慧
  • 主要趨勢
    • 藥物貼片系統的應用日益廣泛
    • 疼痛管理應用的擴展
    • 對受管制藥物釋放的需求
    • 家庭藥物配送的成長
    • 微針技術的創新

第5章 終端用戶產業市場分析

  • 醫院
  • 居家醫療
  • 製藥公司
  • 研究機構
  • 專科診所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球經皮給藥系統市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球經皮給藥系統市場規模、對比及成長率分析
  • 全球經皮給藥系統市場表現：規模與成長，2020-2025年
  • 全球經皮給藥系統市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 依配方類型
  • 藥物貼片、儲庫型、基質型、微儲庫型
  • 透過技術
  • 離子導入、微孔化
  • 透過使用
  • 疼痛管理、中樞神經系統、心血管疾病、戒菸支持
  • 最終用戶
  • 醫院、居家醫療、製藥公司、研究機構
  • 按類型細分：含藥貼劑
  • 單層含藥黏合劑，多層含藥黏合劑
  • 按類型細分：儲層類型
  • 凝膠儲液系統、液體儲液系統、固體儲液系統
  • 按類型細分：矩陣類型
  • 聚合物基質系統、脂質基質系統、水凝膠基質系統
  • 按類型細分：微型儲庫類型
  • 微針陣列、微乳液儲庫、奈米顆粒注射儲庫

第10章 區域與國別分析

  • 全球經皮給藥系統市場：依地區分類，歷史資料及預測（2020-2025年、2025-2030年預測、2035年預測）
  • 全球經皮給藥系統市場：依國家分類，歷史資料及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 經皮給藥系統市場：競爭格局及市場佔有率（2024年）
  • 經皮給藥系統市場：公司評估矩陣
  • 經皮給藥系統市場：公司概況
    • Pfizer Inc.
    • Johnson & Johnson
    • Bayer AG
    • Novartis AG
    • 3M Company

第37章 其他大型企業和創新企業

  • Teva Pharmaceutical Industries Ltd., Mylan NV, Skyepharma PLC, Noven Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Watson Pharmaceuticals Inc., Endo International plc, Transdermal Technologies Inc., Actavis Inc., LTS Lohmann Therapie-Systeme AG, Perrigo Company plc, Nitto Denko Corporation, Zydus Lifesciences Ltd., Dr. Reddy's Laboratories Ltd., Sandoz International GmbH

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年經皮給藥系統市場：提供新機會的國家
  • 2030年經皮給藥系統市場：充滿新機會的細分市場
  • 2030年經皮給藥系統市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第41章附錄

簡介目錄
Product Code: PH4MTDDS01_G26Q1

Transdermal drug delivery systems are methods of administering medication through the skin, allowing for controlled and continuous release of the drug into the bloodstream over time. These systems typically come in the form of a patch or similar device that adheres to the skin, gradually delivering medication while offering benefits such as bypassing the digestive system and maintaining consistent drug levels in the body.

The primary formulation types of transdermal drug delivery systems include drug-in-patch, reservoir type, matrix type, and microreservoir type. The drug-in-patch formulation is especially popular in the consumer health sector due to its convenience, notably for treatments like nicotine replacement and hormone therapy patches. Key technologies in transdermal delivery include iontophoresis and microporation. Applications span pain management, central nervous system disorders, cardiovascular diseases, and smoking cessation, and these systems are utilized across hospitals, home healthcare, pharmaceutical companies, and research institutes.

Tariffs have influenced the transdermal drug delivery systems market by increasing the cost of imported active pharmaceutical ingredients, polymers, and electronic components used in advanced patches and iontophoresis devices, leading to higher manufacturing expenses and pricing pressures. The impact is most significant across drug-in-patch, reservoir, and microreservoir systems, with Asia-Pacific and North American regions being the most affected due to their dependence on cross-border pharmaceutical and medical device supply chains. However, tariffs are also encouraging pharmaceutical companies to localize production, strengthen domestic manufacturing, and invest in supply chain resilience, which is gradually improving regional self-sufficiency and long-term market stability.

The transdermal drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides transdermal drug delivery systems market statistics, including transdermal drug delivery systems industry global market size, regional shares, competitors with a transdermal drug delivery systems market share, detailed transdermal drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the transdermal drug delivery systems industry. This transdermal drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The transdermal drug delivery systems market size has grown strongly in recent years. It will grow from $40.01 billion in 2025 to $43.09 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to oral drug limitations, chronic disease prevalence, patient compliance needs, patch technology development, hospital drug delivery usage.

The transdermal drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $57.94 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to self-administered therapy growth, wearable healthcare devices, chronic disease burden, drug delivery innovation, outpatient care expansion. Major trends in the forecast period include growing adoption of drug-in-patch systems, expansion of pain management applications, demand for controlled drug release, growth of home-based drug delivery, innovation in microneedle technology.

The increasing prevalence of chronic diseases is expected to drive the growth of the transdermal drug delivery systems market in the coming years. Chronic diseases are long-term health conditions that require ongoing management, such as diabetes or heart disease, and can limit daily activities. The rise in these diseases is partly due to more sedentary lifestyles, as reduced physical activity contributes to weight gain, poor cardiovascular health, and metabolic imbalances. Transdermal drug delivery systems play a key role in chronic disease management by providing continuous, controlled release of medication through the skin, improving patient adherence and maintaining stable therapeutic levels. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes, a number projected to more than double to 1.3 billion by 2050. Consequently, the growing prevalence of chronic diseases is supporting the expansion of the transdermal drug delivery systems market.

Key companies in the transdermal drug delivery systems market are focusing on technological innovations, such as microneedle technology, to enhance drug absorption and improve patient compliance. Microneedle technologies are minimally invasive devices that deliver drugs painlessly through the skin, providing an alternative to traditional injections. For instance, in October 2024, Daewoong Pharmaceutical Co. Ltd., a South Korea-based company, launched its microneedle platform CLOPAM. This technology improves drug delivery efficiency, reduces the discomfort associated with injections, and enables controlled, sustained release of medication. Its primary goal is to provide a painless, consistent alternative to oral or injectable medications, enhancing both patient adherence and treatment outcomes.

In August 2024, Insud Pharma S.L., a Spain-based global pharmaceutical company, acquired Agile Therapeutics Inc. for approximately $0.045 billion. This acquisition enables Insud Pharma to strengthen its women's health and transdermal drug delivery capabilities by integrating Agile's flagship product, Twirla, a transdermal contraceptive patch delivering levonorgestrel and ethinyl estradiol through the skin. Agile Therapeutics Inc., based in the US, specializes in women's healthcare and transdermal drug delivery technologies.

Major companies operating in the transdermal drug delivery systems market are Pfizer Inc., Johnson & Johnson, Bayer AG, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Skyepharma PLC, Noven Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Watson Pharmaceuticals Inc., Endo International plc, Transdermal Technologies Inc., Actavis Inc., LTS Lohmann Therapie-Systeme AG, Perrigo Company plc, Nitto Denko Corporation, Zydus Lifesciences Ltd., Dr. Reddy's Laboratories Ltd., Sandoz International GmbH, Cipla Ltd., Sun Pharmaceutical Industries Ltd., Luye Pharma Group, Mundipharma International Ltd., Aveva Drug Delivery Systems Ltd.

North America was the largest region in the transdermal drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transdermal drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the transdermal drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transdermal drug delivery systems market consists of sales of gels, creams, and microneedles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transdermal Drug Delivery Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses transdermal drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transdermal drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transdermal drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Formulation Type: Drug-In-Patch; Reservoir Type; Matrix Type; Microreservoir Type
  • 2) By Technology: Iontophoresis; Microporation
  • 3) By Application: Pain Management; Central Nervous System; Cardiovascular Diseases; Smoking Cessation
  • 4) By End User: Hospitals; Home Healthcare; Pharmaceutical Companies; Research Institutes
  • Subsegments:
  • 1) By Drug-In-Patch: Single-layer Drug-in-Adhesive; Multi-layer Drug-in-Adhesive
  • 2) By Reservoir Type: Gel Reservoir Systems; Liquid Reservoir Systems; Solid Reservoir Systems
  • 3) By Matrix Type: Polymer Matrix Systems; Lipid Matrix Systems; Hydrogel Matrix Systems
  • 4) By Microreservoir Type: Microneedle Arrays; Microemulsion Reservoirs; Nanoparticle-Infused Reservoirs
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Bayer AG; Novartis AG; 3M Company; Teva Pharmaceutical Industries Ltd.; Mylan N.V.; Skyepharma PLC; Noven Pharmaceuticals Inc.; Hisamitsu Pharmaceutical Co. Inc.; Watson Pharmaceuticals Inc.; Endo International plc; Transdermal Technologies Inc.; Actavis Inc.; LTS Lohmann Therapie-Systeme AG; Perrigo Company plc; Nitto Denko Corporation; Zydus Lifesciences Ltd.; Dr. Reddy's Laboratories Ltd.; Sandoz International GmbH; Cipla Ltd.; Sun Pharmaceutical Industries Ltd.; Luye Pharma Group; Mundipharma International Ltd.; Aveva Drug Delivery Systems Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Transdermal Drug Delivery Systems Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Transdermal Drug Delivery Systems Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Transdermal Drug Delivery Systems Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Transdermal Drug Delivery Systems Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Growing Adoption Of Drug-In-Patch Systems
    • 4.2.2 Expansion Of Pain Management Applications
    • 4.2.3 Demand For Controlled Drug Release
    • 4.2.4 Growth Of Home-Based Drug Delivery
    • 4.2.5 Innovation In Microneedle Technology

5. Transdermal Drug Delivery Systems Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Home Healthcare
  • 5.3 Pharmaceutical Companies
  • 5.4 Research Institutes
  • 5.5 Specialty Clinics

6. Transdermal Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Transdermal Drug Delivery Systems Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Transdermal Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Transdermal Drug Delivery Systems Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Transdermal Drug Delivery Systems Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Transdermal Drug Delivery Systems Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Transdermal Drug Delivery Systems Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Transdermal Drug Delivery Systems Market Segmentation

  • 9.1. Global Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug-In-Patch, Reservoir Type, Matrix Type, Microreservoir Type
  • 9.2. Global Transdermal Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Iontophoresis, Microporation
  • 9.3. Global Transdermal Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pain Management, Central Nervous System, Cardiovascular Diseases, Smoking Cessation
  • 9.4. Global Transdermal Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Home Healthcare, Pharmaceutical Companies, Research Institutes
  • 9.5. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Drug-In-Patch, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive
  • 9.6. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Reservoir Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gel Reservoir Systems, Liquid Reservoir Systems, Solid Reservoir Systems
  • 9.7. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Matrix Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymer Matrix Systems, Lipid Matrix Systems, Hydrogel Matrix Systems
  • 9.8. Global Transdermal Drug Delivery Systems Market, Sub-Segmentation Of Microreservoir Type, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microneedle Arrays, Microemulsion Reservoirs, Nanoparticle-Infused Reservoirs

10. Transdermal Drug Delivery Systems Market Regional And Country Analysis

  • 10.1. Global Transdermal Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Transdermal Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Transdermal Drug Delivery Systems Market

  • 11.1. Asia-Pacific Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Transdermal Drug Delivery Systems Market

  • 12.1. China Transdermal Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Transdermal Drug Delivery Systems Market

  • 13.1. India Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Transdermal Drug Delivery Systems Market

  • 14.1. Japan Transdermal Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Transdermal Drug Delivery Systems Market

  • 15.1. Australia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Transdermal Drug Delivery Systems Market

  • 16.1. Indonesia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Transdermal Drug Delivery Systems Market

  • 17.1. South Korea Transdermal Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Transdermal Drug Delivery Systems Market

  • 18.1. Taiwan Transdermal Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Transdermal Drug Delivery Systems Market

  • 19.1. South East Asia Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Transdermal Drug Delivery Systems Market

  • 20.1. Western Europe Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Transdermal Drug Delivery Systems Market

  • 21.1. UK Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Transdermal Drug Delivery Systems Market

  • 22.1. Germany Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Transdermal Drug Delivery Systems Market

  • 23.1. France Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Transdermal Drug Delivery Systems Market

  • 24.1. Italy Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Transdermal Drug Delivery Systems Market

  • 25.1. Spain Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Transdermal Drug Delivery Systems Market

  • 26.1. Eastern Europe Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Transdermal Drug Delivery Systems Market

  • 27.1. Russia Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Transdermal Drug Delivery Systems Market

  • 28.1. North America Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Transdermal Drug Delivery Systems Market

  • 29.1. USA Transdermal Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Transdermal Drug Delivery Systems Market

  • 30.1. Canada Transdermal Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Transdermal Drug Delivery Systems Market

  • 31.1. South America Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Transdermal Drug Delivery Systems Market

  • 32.1. Brazil Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Transdermal Drug Delivery Systems Market

  • 33.1. Middle East Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Transdermal Drug Delivery Systems Market

  • 34.1. Africa Transdermal Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Transdermal Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Transdermal Drug Delivery Systems Market Regulatory and Investment Landscape

36. Transdermal Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 36.1. Transdermal Drug Delivery Systems Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Transdermal Drug Delivery Systems Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Transdermal Drug Delivery Systems Market Company Profiles
    • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. 3M Company Overview, Products and Services, Strategy and Financial Analysis

37. Transdermal Drug Delivery Systems Market Other Major And Innovative Companies

  • Teva Pharmaceutical Industries Ltd., Mylan N.V., Skyepharma PLC, Noven Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Watson Pharmaceuticals Inc., Endo International plc, Transdermal Technologies Inc., Actavis Inc., LTS Lohmann Therapie-Systeme AG, Perrigo Company plc, Nitto Denko Corporation, Zydus Lifesciences Ltd., Dr. Reddy's Laboratories Ltd., Sandoz International GmbH

38. Global Transdermal Drug Delivery Systems Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Transdermal Drug Delivery Systems Market

40. Transdermal Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 40.1 Transdermal Drug Delivery Systems Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Transdermal Drug Delivery Systems Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Transdermal Drug Delivery Systems Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer